Skip to main content

Advertisement

Log in

Syndrome of inappropriate secretion of antidiuretic hormone induced by tacrolimus in a patient with systemic lupus erythematosus

  • Case Report
  • Published:
Modern Rheumatology

Abstract

We describe the first reported case of a syndrome of inappropriate secretion of antidiuretic hormone (SIADH) induced by low-dose tacrolimus in a patient with autoimmune disease. A 41-year-old man with systemic lupus erythematosus (SLE) developed hyponatremia induced by SIADH after administration of tacrolimus (0.06 mg/kg per day). In this case, the hyponatremia promptly resolved upon withdrawal of tacrolimus. This case strongly suggests that SIADH is a potentially important complication of tacrolimus administration, irrespective of dosage, and should be borne in mind whenever the drug is used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fleischmann R, Iqbal I, Stern RL. Tacrolimus in rheumatoid arthritis. Expert Opin Pharmacother. 2006;7:91–8.

    Article  CAS  PubMed  Google Scholar 

  2. Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Lupus. 2007;16:896–900.

    Article  CAS  PubMed  Google Scholar 

  3. Marchewka Z, Kuźniar J, Zynek-Litwin M, Falkiewicz K, Szymańska B, Roszkowska A, et al. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers. Transpl Proc. 2009;41:1660–5.

    Article  CAS  Google Scholar 

  4. Atkison P, Joubert G, Barron A, Grant D, Paradis K, Seidman E, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet. 1995;345:894–6.

    Article  CAS  PubMed  Google Scholar 

  5. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13:313–26.

    Article  CAS  PubMed  Google Scholar 

  6. Tamura K, Fujimura T, Tsutsumi T, Nakamura K, Ogawa T, Atumaru C, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation. 1995;59:1606–13.

    CAS  PubMed  Google Scholar 

  7. Maemori M, Hayashi T, Ikeda H, Obata T, Tsukuda H, Nishimura S, et al. Syndrome of inappropriate secretion of antidiuretic hormone induced by tacrolimus hydrate. Tumor Res. 2004;39:7–10.

    Google Scholar 

  8. Azuma T, Narumi H, Kojima K, Nawa Y, Hara M. Hyponatremia during administration of tacrolimus in an allogeneic bone marrow transplant recipient. Int J Hematol. 2003;78:268–9.

    Article  PubMed  Google Scholar 

  9. O’Regan S, Carson S, Chesney RW, Drummond KN. Electrolyte and acid-base disturbances in the management of leukemia. Blood. 1977;49:345–53.

    PubMed  Google Scholar 

  10. Harper PG, Souhami RL, Spiro SG, Geddes DM, Guimaraes M, Fearon F, et al. Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep. 1982;66:463–70.

    CAS  PubMed  Google Scholar 

  11. Fabrice GK, Guy D. Inappropriate secretion of ADH and central diabetes insipidus are related to antiphospholipid antibodies in SLE—case report and review of the literature. Nephrol Dial Transpl. 2006;21:3311–5.

    Article  Google Scholar 

  12. Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS. The systemic lupus activity measure-revised, the Mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31:1934–40.

    PubMed  Google Scholar 

  13. Honjoh H, Kobayashi S, Okada H, Ikeda T. Inappropriate secretion of antidiuretic hormone (SIADH) in a patient with pleurisy related to adult onset Still’s disease. Clin Nephrol. 1995;44:400–1.

    CAS  PubMed  Google Scholar 

  14. Chan TY. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging. 1997;11:27–44.

    Article  CAS  PubMed  Google Scholar 

  15. Higgins R, Ramaiyan K, Dasgupta T, Kanji H, Fletcher S, Lam F, et al. Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities. Nephrol Dial Transpl. 2004;19:444–50.

    Article  CAS  Google Scholar 

  16. Sakamoto K, Yamada K, Arita S, Hamaguchi K, Kashiwabara H, Yokoyama T. Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. Transpl Proc. 1995;27:826–8.

    CAS  Google Scholar 

  17. Heering P, Ivens K, Aker S, Grabensee B. Distal tubular acidosis induced by FK506. Clin Transpl. 1998;12:465–71.

    CAS  Google Scholar 

  18. Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E. A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer. 1979;44:896–8.

    Article  CAS  PubMed  Google Scholar 

  19. Winkler M, Christians U. A risk-benefit assessment of tacrolimus in transplantation. Drug Saf. 1995;12:348–57.

    Article  CAS  PubMed  Google Scholar 

  20. Gold R, Schneider-Gold C. Current and future standards in treatment of myasthenia gravis. Neurotherapeutics. 2008;5:535–41.

    Article  CAS  PubMed  Google Scholar 

  21. Naniwa T, Watanabe M, Banno S, Maeda T. Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies. Rheumatol Int. 2009;29:1287–91.

    Article  CAS  PubMed  Google Scholar 

  22. Oki E, Tsugawa K, Suzuki K, Tanaka H. Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus (in Japanese). Nippon Jinzo Gakkai Shi. 2007;49:1020–4.

    PubMed  Google Scholar 

  23. Benson A, Barrett T, Sparberg M, Buchman AL. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn’s disease: a single-center experience. Inflamm Bowel Dis. 2008;14:7–12.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichiro Suemori.

About this article

Cite this article

Suemori, K., Hasegawa, H., Nanba, C. et al. Syndrome of inappropriate secretion of antidiuretic hormone induced by tacrolimus in a patient with systemic lupus erythematosus. Mod Rheumatol 21, 97–100 (2011). https://doi.org/10.1007/s10165-010-0350-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-010-0350-2

Keywords

Navigation